Top
Europe Human Coagulation Factor VIII Market 2016 Industry Trend and Forecast 2021
Category : Diagnostic and Biotech  | Published Date : May-2016 | Pages : 134
enquire GET DISCOUNT

Europe Human Coagulation Factor VIII Market

Trend and Forecast 2021 offers an in-depth analysis overview of the industry dynamics, current and future market trends, profile of key manufacturers, detailed segmentation and forecast along with the strategies adopted by key market players to consolidate their market positions. The analysis covers key industry parameters in terms of market definition, classification of the product, materials specification, key manufacturing technology and processes and the price trends of major products across different regions. This report offers an in-depth insight into the current market trends, key market drivers and the restraining factors, market challenges along with burning issues along with the key market imperatives impacting the growth of the market.

The study on Europe Human Coagulation Factor VIII Market 2016 industry makes a detailed analysis of the upstream raw materials demand, downstream client demand and future industry growth prospects. The study explores the profile of manufacturing plants across major regions in terms of their raw materials analysis, technology sources along with R&D status of the key products. The study highlights the pricing structure of the product offerings of the major companies across different countries and the reasons responsible for the change. The study provides segmentation and market share in major geographical locations along with a detailed market forecast of the market in the aforementioned regions amid the period 2009-2019.

Relevant and accurate statistics on the key market growth parameters such as product specification, capacity utilization of major manufacturing units, production value, and market size and share based on geography, region and application are covered in this report. Further the report on Europe Human Coagulation Factor VIII Market 2016 industry highlights the dominant market conditions in terms of major technological innovations brought about by major global vendors.

The study also takes a closer look at the feasibility analysis of various marketing channels used by stakeholders and companies. This would help new entrant market players to devise their competitive strategy accordingly. The analysis also offers the status of the status of important projects in the pipeline along with SWOT analysis of the projects already implemented.
Table of Contents 1 Industry Overview 1
1.1 Definition and Specifications of Human Coagulation Factor VIII 1
1.1.1 Definition of Human Coagulation Factor VIII 1
1.1.2 Specifications of Human Coagulation Factor VIII 2
1.2 Classification of Human Coagulation Factor VIII 3
1.2.1 Recombinant Factor VIII 3
1.2.2 Plasma-derived Factor VIII 4
1.3 Applications of Human Coagulation Factor VIII 5
1.3.1 Hemophilia A 6
1.3.2 Spontanous + Traum 6
1.3.3 Surgical 7
1.4 Industry Chain Structure of Human Coagulation Factor VIII 7
1.5 Industry Overview of Human Coagulation Factor VIII 8
1.6 Industry Policy Analysis of Human Coagulation Factor VIII 9
1.7 Industry News Analysis of Human Coagulation Factor VIII 9
2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII 11
2.1 Bill of Materials (BOM) of Human Coagulation Factor VIII 11
2.1.1 Global Plasma Volume Analysis 12
2.1.2 Numbers of Plasma Collection Stations Analysis 14
2.1.3 Price Comparison of United States Cell Culture Media 15
2.2 Equipment Suppliers Analysis of Human Coagulation Factor VIII 15
2.3 Labor Cost Analysis of Human Coagulation Factor VIII 18
2.4 Other Costs Analysis of Human Coagulation Factor VIII 19
2.5 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII 20
2.6 Manufacturing Process Analysis of Human Coagulation Factor VIII 20
3 Technical Data and Manufacturing Plants Analysis 22
3.1 Commercial Production Date of Europe Key Manufacturers in 2015 22
3.2 Manufacturing Plants Distribution of Europe Key Human Coagulation Factor VIII Manufacturers in 2015 22
3.3 R&D Status and Technology Source of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 23
4 Production Analysis of Human Coagulation Factor VIII by Regions, Product Types, and Applications 24
4.1 Europe Production of Human Coagulation Factor VIII by Regions (Key State) 2011-2016 24
4.2 Europe Production of Human Coagulation Factor VIII by Product Types 2011-2016 28
4.3 Europe Sales of Human Coagulation Factor VIII by Applications 2011-2016 31
4.4 Price Analysis of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 35
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Human Coagulation Factor VIII 2011-2016 36
5 Consumption Volume and Consumption Value Analysis of Human Coagulation Factor VIII by Regions 37
5.1 Europe Consumption Volume of Human Coagulation Factor VIII by Regions 2011-2016 37
5.2 Europe Consumption Value of Human Coagulation Factor VIII by Regions 2011-2016 41
5.3 Europe Consumption Price Analysis of Human Coagulation Factor VIII by Regions 2011-2016 45
6 Analysis of Human Coagulation Factor VIII Production, Supply, Sales and Market Status 2011-2016 46
6.1 Capacity, Production, Sales, and Revenue of Human Coagulation Factor VIII 2011-2016 46
6.2 Production Market Share and Sales Market Share of Human Coagulation Factor VIII 2011-2016 51
6.3 Sales Overview of Human Coagulation Factor VIII 2011-2016 57
6.4 Supply, Consumption and Gap of Human Coagulation Factor VIII 2011-2016 59
6.5 Import, Export and Consumption of Human Coagulation Factor VIII 2011-2016 59
6.6 Cost, Price, Revenue and Gross Margin of Human Coagulation Factor VIII 2011-2016 59
7 Analysis of Human Coagulation Factor VIII Industry Key Manufacturers 62
7.1 Baxter 62
7.1.1 Company Profile 62
7.1.2 Product Picture and Specifications 63
7.1.2.1 ADVATE (Recombinant coagulation factor VIII) 63
7.1.2.2 Recombinant 63
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue 64
7.2 Bayer 65
7.2.1 Company Profile 65
7.2.2 Product Picture 66
7.2.2.1 Kogenate® FS, antihemophilic factor (recombinant) 66
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue 67
7.3 Pfizer 68
7.3.1 Company Profile 68
7.3.2 Product Picture 70
7.3.2.1 XYNTHA® (antihemophilic factor (recombinant)) 70
7.3.2.2 REFACTO® (antihemophilic factor (recombinant)) 71
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue 71
7.4 CSL 73
7.4.1 Company Profile 73
7.4.2 Product Picture and Specifications 74
7.4.2.1 Helixate FS (Recombinant coagulation factor VIII) 74
7.4.2.2 Helixate® NexGen 75
7.4.2.3 Humate-P® 75
7.4.2.4 Biostate® 76
7.4.2.5 Beriate? (Human coagulation factor VIII) 76
7.4.2.6 Monoclate-P® 77
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue 77
7.5 Grifols 79
7.5.1 Company Profile 79
7.5.2 Product Picture and Specification 80
7.5.2.1 Fanhdi® 80
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue 80
7.6 Octapharma 82
7.6.1 Company Profile 82
7.6.2 Product Picture and Specifications 83
7.6.2.1 nuwiq®( human coagulation factor VIII recombinant DNA) 83
7.6.2.2 octanate® 84
7.6.2.3 wilate® 84
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue 85
7.7 BPL 87
7.7.1 Company Profile 87
7.7.2 Product Picture 88
7.7.2.1 Optivate 88
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue 89
7.8 Kedrion 90
7.8.1 Company Profile 90
7.8.2 Product Picture 91
7.8.2.1 Human Coagulation Factor VIII (10ml) 91
7.8.2.2 Human Coagulation Factor VIII (5ml) 92
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue 92
8 Price and Gross Margin Analysis 94
8.1 Analysis of Price 94
8.2 Gross Margin Analysis 94
8.3 Price Comparison by Regions 95
8.4 Price Analysis of Different Human Coagulation Factor VIII Product Types 95
8.5 Gross Margin Analysis of Different Human Coagulation Factor VIII Applications 95
9 Marketing Trader or Distributor Analysis of Human Coagulation Factor VIII 97
9.1 Marketing Channels Status of Human Coagulation Factor VIII 97
9.2 Traders or Distributors of Human Coagulation Factor VIII with Contact Information 98
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Human Coagulation Factor VIII 99
9.4 Europe Import, Export and Trade Analysis of Human Coagulation Factor VIII 99
10 Development Trend of Human Coagulation Factor VIII Industry 2016-2021 100
10.1 Capacity and Production Overview of Human Coagulation Factor VIII 2016-2021 100
10.2 Production Market Share by Product Types of Human Coagulation Factor VIII 2016-2021 101
10.3 Sales and Sales Revenue Overview of Human Coagulation Factor VIII 2016-2021 102
10.4 Europe Sales of Human Coagulation Factor VIII by Applications 2016-2021 103
10.5 Import, Export and Consumption of Human Coagulation Factor VIII 2016-2021 104
10.6 Cost, Price, Revenue and Gross Margin of Human Coagulation Factor VIII 2016-2021 105
11 Industry Chain Suppliers of Human Coagulation Factor VIII with Contact Information 106
11.1 Major Raw Materials Suppliers of Human Coagulation Factor VIII with Contact Information 106
11.2 Manufacturing Equipment Suppliers of Human Coagulation Factor VIII with Contact Information 107
11.3 Major Players of Human Coagulation Factor VIII with Contact Information 110
11.4 Key Consumers of Human Coagulation Factor VIII with Contact Information 111
11.5 Supply Chain Relationship Analysis of Human Coagulation Factor VIII 112
12 New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113
12.1 New Project SWOT Analysis of Human Coagulation Factor VIII 113
12.2 New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113
13 Conclusion of the Europe Human Coagulation Factor VIII Industry Report 2015 115
List of Tables and FiguresListList

Figure Picture of Human Coagulation Factor VIII (Plasma-derived Factor VIII) 2
Table Specifications of Human Coagulation Factor VIII 2
Table Specification Comparison of Human Coagulation Factor VIII 3
Figure Europe Production Market Share of Human Coagulation Factor VIII by Type in 2015 3
Figure Recombinant Factor VIII Picture 4
Figure Plasma-derived Factor VIII Picture 4
Table Applications of Human Coagulation Factor VIII 5
Figure 2015 Europe Human Coagulation Factor VIII Major Applications Sales Share 5
Figure Typical Application in Hemophilia A 6
Figure Typical Application in Spontanous + Traum 6
Figure Typical Application in Surgical 7
Figure Industry Chain Structure of Human Coagulation Factor VIII 7
Table Europe Human Coagulation Factor VIII Major Manufacturers 8
Figure Europe Human Coagulation Factor VIII Major Regions Status in 2015 8
Table Industry Policy of Human Coagulation Factor VIII 9
Table Industry News List of Human Coagulation Factor VIII 9
Table Bill of Materials (BOM) of Human Coagulation Factor VIII 11
Table Global Plasma Volume by Region 2011-2016 (M Liter) 12
Table Global Plasma Market Share by Region 2011-2016 12
Figure Global Plasma Market Share by Region 2011 13
Figure Global Plasma Market Share by Region 2015 13
Table Global Major Manufacturers Plasma volume 2011-2016 (M Liter) 14
Table Numbers of Blood Collection Stations 2011-2016 14
Figure Price Comparison of Cell Culture Media 2011-2016 15
Table the key equipment of Human Coagulation Factor VIII 15
Figure Equipment Specification of Industrial Centrifuges 17
Figure Equipment Specification of Industrial Incubator 18
Figure European 2014 Estimated Hourly Labor Costs 18
Table 2015 Europe Electricity Price of Industry (USD/KW•h) by Country 19
Table Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII in 2015 20
Figure Manufacturing Process Analysis of Recombinant Factor VIII 20
Figure Manufacturing Process Analysis of Plasma-derived Factor VIII 21
Table Commercial Production Date of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 22
Table Manufacturing Plants Distribution of Europe Key Human Coagulation Factor VIII Manufacturers in 2015 22
Table R&D Status and Technology Source of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 23
Table Europe Production of Human Coagulation Factor VIII by Regions 2011-2016 (K Bottles) 24
Table Europe Production Market Share of Human Coagulation Factor VIII by Regions 2011-2016 24
Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2011 25
Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2012 25
Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2013 26
Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2014 26
Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2015 27
Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2016 27
Table Europe Production of Human Coagulation Factor VIII by Product Types in 2011-2016 (K Bottles) 28
Table Europe Production Market Share of Human Coagulation Factor VIII by Product Types in 2011-2016 28
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2011 28
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2012 29
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2013 29
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2014 30
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2015 30
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2016 31
Table Europe Sales of Human Coagulation Factor VIII by Applications 2011-2016 (K Bottles) 31
Table Europe Sales Market Share of Human Coagulation Factor VIII by Applications 2011-2016 31
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2011 32
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2012 32
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2013 33
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2014 33
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2015 34
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2016 34
Figure Price Comparison of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 (USD/Bottle) 35
Table Europe Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Human Coagulation Factor VIII 2011-2016 36
Table Europe Consumption Volume of Human Coagulation Factor VIII by Regions 2011-2016 (K Bottles) 37
Table Europe Consumption Volume Market Share of Human Coagulation Factor VIII by Regions 2011-2016 37
Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2011 38
Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2012 38
Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2013 39
Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2014 39
Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2015 40
Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2016 40
Table Europe Consumption Value of Human Coagulation Factor VIII by Regions 2011-2016 (M USD) 41
Table Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions 2011-2016 41
Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2011 42
Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2012 42
Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2013 43
Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2014 43
Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2015 44
Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2016 44
Table Consumption Price of Human Coagulation Factor VIII by Regions 2011-2016 (USD/Bottle) 45
Table Europe and Major Manufacturers Capacity of Human Coagulation Factor VIII 2011-2016 (K Bottles) 46
Table Europe Capacity Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 46
Table Europe and Major Manufacturers Production of Human Coagulation Factor VIII 2011-2016 (K Bottles) 47
Table Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 47
Table Europe and Major Manufacturers Sales of Human Coagulation Factor VIII 2011-2016 (K Bottles) 47
Table Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 48
Table Europe and Major Manufacturers Sales Revenue of Human Coagulation Factor VIII 2011-2016 (M USD) 48
Table Europe Sales Revenue Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 49
Figure Europe Capacity (K Bottles), Production (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2011-2016 49
Figure Europe Capacity Utilization Rate of Human Coagulation Factor VIII 2011-2016 50
Figure Europe Sales Revenue (M USD) and Growth Rate of Human Coagulation Factor VIII 2011-2016 50
Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2011 51
Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2012 51
Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2013 52
Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2014 52
Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2015 53
Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2016 53
Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2011 54
Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2012 54
Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2013 55
Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2014 55
Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2015 56
Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2016 56
Figure Europe Sales (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2011-2016 57
Table Europe and Major Manufacturers Local Sales of Human Coagulation Factor VIII 2011-2016 (K Bottles) 58
Table Europe and Major Manufacturers Export of Human Coagulation Factor VIII 2011-2016 (K Bottles) 58
Table Europe Supply, Consumption and Gap of Human Coagulation Factor VIII 2011-2016 (K Bottles) 59
Table Europe Import, Export and Consumption of Human Coagulation Factor VIII 2011-2016 (K Bottles) 59
Table Price of Europe Human Coagulation Factor VIII Major Manufacturers 2011-2016 (USD/Bottle) 59
Table Gross Margin of Europe Human Coagulation Factor VIII Major Manufacturers 2011-2016 60
Table Europe and Major Manufacturers Revenue of Human Coagulation Factor VIII 2011-2016 (M USD) 60
Table Europe Production (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Revenue (M USD) and Gross Margin of Human Coagulation Factor VIII 2011-2016 61
Table Baxter Company Profile List 62
Figure ADVATE Product Picture of Baxter 63
Figure Recombinant Product Picture of Baxter 63
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Baxter 2011-2016 64
Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Baxter 2011-2016 64
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Baxter 2011-2016 65
Table Bayer Company Profile List 65
Figure Kogenate® FS, antihemophilic factor (recombinant) Product Picture of Bayer 66
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Bayer 2011-2016 67
Figure Human Coagulation Factor VIII Local Sales (K Bottles) and Growth Rate of Bayer 2011-2016 67
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Bayer 2011-2016 68
Table Pfizer Company Profile List 68
Figure XYNTHA® (antihemophilic factor (recombinant)) Product Picture of Pfizer 70
Figure REFACTO® (antihemophilic factor (recombinant)) Product Picture of Pfizer 71
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Pfizer 2011-2016 71
Figure Human Coagulation Factor VIII Local Sales (K Bottles) and Growth Rate of Pfizer 2011-2016 72
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Pfizer 2011-2016 72
Table CSL Company Profile List 73
Figure Helixate FS Product Picture of CSL 74
Figure Helixate® NexGen Product Picture of CSL 75
Figure Humate-P® Product Picture of CSL 75
Figure Biostate® Product Picture of CSL 76
Figure Beriate? Product Picture of CSL 76
Figure Monoclate-P® Product Picture of CSL 77
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of CSL 2011-2016 77
Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of CSL 2011-2016 78
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of CSL 2011-2016 78
Table Grifols Company Profile List 79
Figure Fanhdi® Product Picture of Grifols 80
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Grifols 2011-2016 80
Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Grifols 2011-2016 81
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Grifols 2011-2016 81
Table Octapharma Company Profile List 82
Figure nuwiq® Product Picture of Octapharma 83
Figure octanate® Product Picture of Octapharma 84
Figure wilate® Product Picture of Octapharma 84
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Octapharma 2011-2016 85
Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Octapharma 2011-2016 86
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Octapharma 2011-2016 86
Table BPL Company Profile List 87
Figure Optivate Product Picture of BPL 88
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of BPL 2011-2016 89
Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of BPL 2011-2016 89
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of BPL 2011-2016 90
Table Kedrion Company Profile List 90
Figure Human Coagulation Factor VIII (10ml) Product Picture of Kedrion 91
Figure Human Coagulation Factor VIII (5ml) Product Picture of Kedrion 92
Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Kedrion 2011-2016 92
Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Kedrion 2011-2016 93
Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Kedrion 2011-2016 93
Table Human Coagulation Factor VIII Price by Product Types 2011-2016 (USD/Bottle) 94
Table Human Coagulation Factor VIII Price by Companies 2011-2016 (USD/Bottle) 94
Table Human Coagulation Factor VIII Gross Margin by Companies 2011-2016 94
Table Price Comparison of Human Coagulation Factor VIII by Regions 2011-2016 (USD/Bottle) 95
Table Price of Different Human Coagulation Factor VIII Product Types (USD/Bottle) 95
Table Gross Margin of Different Human Coagulation Factor VIII Applications 95
Figure Marketing Channels Analysis of Human Coagulation Factor VIII 97
Table Traders or Distributors of Human Coagulation Factor VIII with Contact Information 98
Figure Ex-work Price, Channel Price and End Buyer Price of Human Coagulation Factor VIII (USD/Bottle) in 2015 99
Table Europe Import, Export, and Trade of Human Coagulation Factor VIII (K Bottles) 99
Figure Europe Capacity (K Bottles), Production (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2016-2021 100
Figure Europe Capacity Utilization Rate of Human Coagulation Factor VIII 2016-2021 101
Table Europe Human Coagulation Factor VIII Production by Product Types 2011-2016 (K Bottles) 101
Table Europe Human Coagulation Factor VIII Production Market Share by Product Types 2011-2016 101
Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2021 102
Figure Europe Sales (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2016-2021 102
Figure Europe Sales Revenue (Million USD) and Growth Rate of Human Coagulation Factor VIII 2016-2021 103
Figure Europe Sales of Human Coagulation Factor VIII by Applications 2016-2021 (K Bottles) 103
Table Europe Production Market Share of Human Coagulation Factor VIII by Applications 2016-2021 103
Figure Europe Production Market Share of Human Coagulation Factor VIII by Applications in 2021 104
Table Europe Production, Import, Export and Consumption of Human Coagulation Factor VIII 2016-2021 (K Bottles) 104
Table Europe Production (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Revenue (M USD) and Gross Margin of Human Coagulation Factor VIII 2016-2021 105
Table Major Raw Materials Suppliers of Human Coagulation Factor VIII with Contact Information 106
Table Manufacturing Equipment Suppliers of Human Coagulation Factor VIII with Contact Information 107
Table Major Players of Human Coagulation Factor VIII with Contact Information 110
Table Key Consumers of Human Coagulation Factor VIII with Contact Information 111
Figure Supply Chain Relationship Analysis of Human Coagulation Factor VIII 112
Table New Project SWOT Analysis of Human Coagulation Factor VIII 113
Table New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113
Author List 116

...
Publisher Name : QYResearch

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 3600
Enterprise User: US $ 7200

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top